Hepatitis, Autoimmune
Information
- Disease name
- Hepatitis, Autoimmune
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT03941184 | Completed | Spontaneous Coronary Artery Dissection (SCAD) and Autoimmunity | January 1, 1995 | November 10, 2020 | |
| NCT01980745 | Completed | Phase 4 | CHLOROQUINE FOR MAINTENANCE REMISSION OF AUTOIMMUNE HEPATITIS | February 2002 | June 2015 |
| NCT05473403 | Not yet recruiting | N/A | Validation of a Prognostic Score for Steroid Therapy Response in Acute Severe Autoimmune Hepatitis | June 1, 2024 | June 30, 2028 |
| NCT02997878 | Recruiting | Phase 1/Phase 2 | Selected Mesenchymal Stromal Cells to Reduce Inflammation in Patients With PSC and AIH | December 7, 2018 | December 2023 |
| NCT00286663 | Terminated | Autoimmune Hepatitis Study | January 2006 | June 2008 | |
| NCT02994537 | Unknown status | Study of the Clinical Features of Autoimmune Hepatitis | October 2013 | December 31, 2022 | |
| NCT03146884 | Unknown status | Swiss Autoimmune Hepatitis Cohort Study | February 16, 2017 | December 31, 2022 | |
| NCT02936596 | Unknown status | N/A | Remission Induction of Primary Biliary Cholangitis-autoimmune Hepatitis Overlap Syndrome | December 2016 | June 1, 2022 |
| NCT04617561 | Unknown status | Phase 4 | Ursodeoxycholic Acid Combined With Low Dose Glucocorticoid in the Treatment of PBC With AIH Features II | November 1, 2020 | November 1, 2022 |
| NCT02874586 | Unknown status | N/A | Plasma Exchange Combination of Immunosuppressive Regimens for Auto-immune Hepatitis | December 2016 | September 2021 |
| NCT04376528 | Unknown status | Phase 4 | Mycophenolate Mofetil Versus Cyclosporin A in the Treatment of Primary Biliary Cholangitis-autoimmune Hepatitis Overlap Syndrome Due to Nonresponse to Standard Therapy | June 16, 2021 | December 30, 2021 |
| NCT03593460 | Withdrawn | Phase 2 | Phase II AutoImmune Hepatitis | January 1, 2019 | December 31, 2019 |
| NCT02878863 | Withdrawn | Phase 3 | Paeoniflorin Combination of Hepatoprotective Drugs Versus Hepatoprotective Drugs Only for Auto-immune Hepatitis | August 2016 | July 2017 |
- MeSH unique ID (MeSH (Medical Subject Headings))
- D019693